{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:56:42Z","timestamp":1790740602100,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lungcan.2025.108771","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:46:56Z","timestamp":1758941216000},"page":"108771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7596-8927","authenticated-orcid":false,"given":"F.J.","family":"Borm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9775-3073","authenticated-orcid":false,"given":"M.J.","family":"Schelhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.P.","family":"Steeghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2163-2404","authenticated-orcid":false,"given":"C.W.","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.Van","family":"Wijngaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.Van","family":"Egmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.Van","family":"Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5773-7730","authenticated-orcid":false,"given":"T.Van","family":"Wezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.F.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2025.108771_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114233","article-title":"An International Registry Study of Early-Stage NSCLC treatment variations (LUCAEUROPE) in Europe and the USA highlighting variations","volume":"209","author":"Baum","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2025.108771_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126288","article-title":"Anti-PD1\/PD-L1 immunotherapy for non-small cell lung cancer with actionable oncogenic driver mutations","volume":"22","author":"Dantoing","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2025.108771_b0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108771_b0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108771_b0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108771_b0030","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.21037\/jtd-21-617","article-title":"Surgery without preoperative histological confirmation of lung cancer: what is the current clinical practice?","volume":"13","author":"Ghamati","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lungcan.2025.108771_b0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/LBR.0000000000000645","article-title":"The diagnostic accuracy and sensitivity for malignancy of radial-endobronchial ultrasound and electromagnetic navigation bronchoscopy for sampling of peripheral pulmonary lesions: systematic review and meta-analysis","volume":"27","author":"McGuire","year":"2020","journal-title":"J. Bronchology Interv Pulmonol"},{"key":"10.1016\/j.lungcan.2025.108771_b0040","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/thorax.58.11.920","article-title":"Guidelines for radiologically guided lung biopsy","volume":"58","author":"Manhire","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2025.108771_b0045","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/1078-0432.1219.11.3","article-title":"Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer","volume":"11","author":"Fujiwara","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108771_b0050","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2025.108771_b0055","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1515\/cclm-2016-0302","article-title":"Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid","volume":"55","author":"Park","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.lungcan.2025.108771_b0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-018-0772-6","article-title":"Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients","volume":"17","author":"Hur","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lungcan.2025.108771_b0065","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.21037\/atm-21-2579","article-title":"Cell-free DNA from bronchoalveolar lavage fluid (BALF): a new liquid biopsy medium for identifying lung cancer","volume":"9","author":"Zeng","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.lungcan.2025.108771_b0070","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41416-022-01969-2","article-title":"Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules","volume":"127","author":"Zhang","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2025.108771_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108622","article-title":"Bronchial washing fluid supernatant serves as a novel liquid biopsy specimen for genome profiling in advanced non-small cell lung cancer","volume":"205","author":"Wu","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108771_b0080","unstructured":"Oncomine ctPAN, <https:\/\/www.palga.nl\/media\/uploads\/pdf\/8\/0\/803_194-ctpan-lumc.pdf> (."},{"key":"10.1016\/j.lungcan.2025.108771_b0085","unstructured":"Ampliseq CHPv6, <https:\/\/www.palga.nl\/media\/uploads\/pdf\/4\/9\/496_102-chpv6-lumc.pdf> (."},{"key":"10.1016\/j.lungcan.2025.108771_b0090","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jtho.2020.01.019","article-title":"Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing","volume":"15","author":"Cohen","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108771_b0095","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.3233\/TUB-220044","article-title":"Circulating tumor DNA (ctDNA) as a biomarker for lung cancer: early detection, monitoring and therapy prediction","volume":"46","author":"Duffy","year":"2024","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lungcan.2025.108771_b0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2025.108771_b0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026179","article-title":"Somatic TP53 mutations in the era of genome sequencing","volume":"6","author":"Hainaut","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.lungcan.2025.108771_b0110","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1164\/rccm.201806-1178OC","article-title":"Driver mutations in normal airway epithelium elucidate spatiotemporal resolution of lung cancer","volume":"200","author":"Kadara","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lungcan.2025.108771_b0115","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1158\/0008-5472.CAN-15-3064","article-title":"Genomic landscape established by allelic imbalance in the cancerization field of a normal appearing airway","volume":"76","author":"Jakubek","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108771_b0120","unstructured":"Created in BioRender. Van Wijngaarden, K. R."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T04:44:49Z","timestamp":1762490689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225006634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":24,"alternative-id":["S0169500225006634"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108771","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108771"}}